04.11.2014 Views

manual on management of drugs

manual on management of drugs

manual on management of drugs

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Unsatisfactory clinical resp<strong>on</strong>se, adverse reacti<strong>on</strong>s and bad storage<br />

c<strong>on</strong>diti<strong>on</strong>s:<br />

In respect <strong>of</strong> all problems <strong>of</strong> vaccines and sera relating to unsatisfactory<br />

clinical resp<strong>on</strong>ses, adverse reacti<strong>on</strong>s and exposure to bad storage c<strong>on</strong>diti<strong>on</strong>s has<br />

to be reported within 24 hours by teleph<strong>on</strong>e and followed up with samples as<br />

specified below with detail report relevant to the product (lot number, expiry date,<br />

manufacture etc.), storage c<strong>on</strong>diti<strong>on</strong>s, maintenance <strong>of</strong> the cold chain, reacti<strong>on</strong>s<br />

caused, dosage applied etc (sample sending form appears in annexure XVI can be<br />

used) addressed to the Nati<strong>on</strong>al C<strong>on</strong>trol Laboratory (Head / Dept <strong>of</strong> Vaccine<br />

Quality C<strong>on</strong>trol, MRL C<strong>on</strong>tact No. 2698660, 2693532-4 Res. 2597723). Advice<br />

and approval regarding further use <strong>of</strong> the batches should be sought from the<br />

Epidemiologist for all EPI vaccines and from the Director Medical Supplies<br />

Divisi<strong>on</strong> for all N<strong>on</strong>-EPI vaccines.<br />

Please note that the NCL should be c<strong>on</strong>tacted prior to sending the samples.<br />

Sample size for Q.A test-<br />

(1) Single dose vials: sterility test - 5 vials, safety test - 20 vials (2) Multiple dose<br />

vials:<br />

sterility test - 3 vials, safety test - 3 vials<br />

N.B. To be sent in a vaccine carrier maintaining cold chain with copies <strong>of</strong> all<br />

relevant documents.<br />

(2) Same procedure should be followed as pharmaceuticals regarding the handling<br />

<strong>of</strong> product recalling.<br />

Organizati<strong>on</strong> structure <strong>of</strong> the Nati<strong>on</strong>al C<strong>on</strong>trol Laboratory <strong>of</strong> Vaccines<br />

DGHS<br />

Technical Advisory<br />

Committee<br />

DDG (LS)<br />

D/MRI<br />

D\MT&S<br />

Head / NCL<br />

97<br />

Dept <strong>of</strong> Vaccine<br />

QC

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!